DB
IMUX icon

Danske Bank’s Immunic IMUX Stock Holding History

Danske Bank’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31 Buy
+2
New +$25 ﹤0.01% 1042

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Danske Bank's IMUX Position: Q2 2026 in Review

Danske Bank opened a new position in Immunic (IMUX) in Q2 2026: 2 shares worth $31. The stake represents ﹤0.01% of the portfolio and ranks #1042 among its holdings.

30 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Danske Bank held 2 shares of Immunic worth $31 as of Q2 2026.
  • Immunic was a new Danske Bank position in Q2 2026.
  • Immunic made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1042 holding.
  • 30 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.